Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC

NCT05765825 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Extensive-stage Small-cell Lung Cancer

Interventions

DRUG: serplulimab
DRUG: Cisplatin
DRUG: Carboplatin
DRUG: Etoposide
RADIATION: Thoracic radiation therapy (TRT)

Sponsor

Sichuan University